• RegeneRx Biopharmaceuticals Inc., of Rockville, Md., said scientists at the Gladstone Institute of Cardiovascular Disease at the University of California, San Francisco, published animal data in Nature showing that the process of converting nonbeating heart muscle cells into functional beating-heart muscle cells can be enhanced using Thymosin beta 4 (Tbeta4).